GOVERNMENT COUNSEL, LLC

Lobbying for APOTEX CORPORATION · Generic pharmaceutical manufacturer

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Florida · House · Senate · $20,000.00 income · posted Jan 19, 2026

Lobbying activity 1

Manufacturing

Federal policy relating to trade tariffs, strengthening domestic generic production and market access barriers for generic pharmaceuticals.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.